Healthium Medtech, a global medtech company, has agreed to acquire a controlling stake in Paramount Surgimed, a manufacturer and exporter of surgical blades, scalpels and dermal biopsy products.
The non-surgical business of Paramount, including its lifestyle and hygiene business, will be carved out prior to the transaction and retained with the Grover family.
Paramount brings over three decades of specialised manufacturing expertise and has a global footprint built largely through exports, which account for more than 95% of its revenue. The company serves more than 300 OEM and branded customers across 100+ countries, supported by a complete suite of international product registrations, including EU MDR & USFDA. Paramount manufactures over 250 million devices annually, making it one of the largest players in its space.
With this move, Healthium will expand its specialised presence in the surgical consumables segment, where Paramount’s blades and dermal biopsy categories represent a logical extension of its existing business line. This alignment creates a two-way synergy, allowing Healthium to broaden the range of solutions it offers while enabling both organisations to serve their respective customer bases with a more comprehensive product line. Paramount’s scaled manufacturing platform, coupled with its high-quality portfolio, offers a unique value proposition to customers globally.
with a growing portfolio across surgical, post-surgical, advanced wound care, arthroscopy and infection prevention, announced that it
Anish Bafna, CEO & MD of Healthium Medtech, said, “Paramount has earned the trust of clinicians across markets through consistent performance, rigorous execution and strong manufacturing excellence. As Paramount joins the Healthium family, our focus will be on ensuring a smooth integration that preserves what customers value, while also boosting service and supply reliability. We see this as an opportunity to align our collective strengths toward a more competitive global position in surgical consumables.”
Shaily Grover, Managing Director of Paramount Surgimed, said, “We are delighted to partner with Healthium, a leading player in the medtech space, for our surgical disposables business. Their operational expertise and established global reach makes them an ideal partner for our next phase of growth. Paramount has always stood for precision, quality and trust, and we are confident the brand will grow significantly with Healthium. As we join forces, we will use the broader resources of a larger platform and an expanded portfolio to improve reliability and expand access across the markets we serve.”
Daksh Grover, Director of Paramount Surgimed, said, “This partnership paves the way for an unprecedented scale of impact. With our combined product portfolio and global capabilities, we believe we are well positioned to redefine the global surgical consumables landscape and move with a speed and scale never seen before.”
